| 1. |
Hair's the long and short of it |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1207,
1999,
Page 2-2
&NA;,
Preview
|
PDF (898KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
| 2. |
New hope for patients with Parkinson's disease |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1207,
1999,
Page 3-4
Mark Greener,
Preview
|
PDF (1599KB)
|
|
摘要:
Few conditions are more devastating psychologically and physically than Parkinson's disease. The slow erosion of the central dopaminergic neurons controlling muscle movement and tone leads to tremor, rigidity and an inability to move. The disease traps sufferers in their own bodies, and to make patients' prospects even bleaker, levodopa - the mainstay of treatment for 75% of patients with Parkinson's disease - can be associated with devastating adverse events.
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
| 3. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1207,
1999,
Page 5-6
&NA;,
Preview
|
PDF (1526KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
| 4. |
IV-to-oral ofloxacin switch programme cost saving |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1207,
1999,
Page 6-6
&NA;,
Preview
|
PDF (774KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
| 5. |
Prolong enoxaparin sodium therapy after hip surgery |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1207,
1999,
Page 7-7
&NA;,
Preview
|
PDF (805KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
| 6. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1207,
1999,
Page 8-8
&NA;,
Preview
|
PDF (822KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
| 7. |
Eletriptanmaking headway in migraine treatment |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1207,
1999,
Page 9-10
Carmen Innes,
Preview
|
PDF (1758KB)
|
|
摘要:
New research has shown that eletriptan [‘Relpax’] appears to be superior to sumatriptan and caffeine/ergotamine [‘Cafergot’] for the acute treatment of migraine. The results were presented at the 4th Congress of the European Federation of Neurological Societies [Lisbon, Portugal; September 1999]. Also presented were pooled analyses from placebo-controlled trials showing that eletriptan reduces headache recurrence and functional impairment in patients with migraine and is effective at reducing accompanying symptoms such as nausea, vomiting, photophobia and phonophobia.
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
| 8. |
IFN monotherapyretreatment beneficial in certain relapsers |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1207,
1999,
Page 11-11
&NA;,
Preview
|
PDF (739KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
| 9. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1207,
1999,
Page 12-12
&NA;,
Preview
|
PDF (817KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
| 10. |
Are opioids the answer to cancer pain? |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1207,
1999,
Page 13-14
Carmen Innes,
Preview
|
PDF (1654KB)
|
|
摘要:
‘No patient should live or die with unrelieved pain’. These are the words of Dr Michael Levy from the Fox Chase Cancer Center, US, who spoke at the 9th World Congress on Pain [Vienna, Austria; August 1999]. Opioids play a central role in the relief of cancer pain and Dr Levy explained this role in some detail. He said that controlled-release opioids in particular allow patients to have continuous relief from cancer pain, and many studies presented at the meeting focused on the advantages of controlled-release oxycodone.
ISSN:1173-8324
出版商:ADIS
年代:1999
数据来源: ADIS
|
首页
